Meet Stockholm’s most promising life science companies
On May 22nd 2013, the 14th annual BioEquity Europe is being held in Stockholm. The conference offers a unique possibility to meet companies listed on Stockholm-Uppsala Life Science Investment Hotlist during an exclusive showcase.
The hotlist features carefully selected, investment-ready Stockholm-Uppsala based companies on the cutting edge of life science. Hotlist companies presenting during this exclusive showcase are:
Abera Bioscience, BinaryBio, BioLamina, Biovica International, Corline Systems AB, Diamyd, Inerventions, IRRAS, Key To Lead, ModPro, Premune, Senzime, Spiber, Swetox, XBrane Bioscience, XSpray.
The showcase is arranged by Stockholm Business Region Development and the County Administrative Board of Stockholm.
Date: Wednesday, May 22th, 10:45-11:45 am.
Venue: Sheraton hotel, Stockholm, conference room Haga 3.
For registration and more information: Ylva Hultman-Erlandsson, Business Development Manager, Stockholm Business Region Development, +46 70 472 80 65, ylva.hultman@stockholm.se
Full programme: www.biocentury.com/conferences/bioequityeurope
Now celebrating its 14th meeting, BioEquity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. BioEquity Europe has showcased more than 500 leading European companies to thousands of investment and pharma business development professionals.
Stockholm-Uppsala Life Science Investment Hotlist is a project defining investment opportunities for foreign investors in the Stockholm region.
Stockholm Business Region
Stockholm Business Region is the official investment promotion agency for the Stockholm region, one of Europe’s most dynamic regions. With continual high growth, world-leading clusters within life science and ICT, and as a centre for fashion and design, Stockholm is the natural capital of Scandinavia.